Extensively drug-resistant tuberculosis: a new face to an old pathogen.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 19630575.
- Also identified by DOI 10.1146/annurev.med.60.053107.103955 and PMC identifier PMC2062482.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The presence and consequences of resistance to drugs used for the treatment of tuberculosis have long been neglected. The recent detection and recognition of widespread multiple-drug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis have raised interest and concern among clinicians and public health authorities globally. In this article, we describe the current global status of drug-resistant tuberculosis. We discuss the development of resistance, current management, and strategies for control.